Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Brainsway (BWAY - Free Report) is a commercial stage medical device company which is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. The Zacks Consensus Estimate for its current year earnings has been revised almost 10.81% downward over the last 60 days.
CareMax (CMAX - Free Report) is a technology-enabled care platform providing value-based care and chronic disease management to seniors. The Zacks Consensus Estimate for its current year earnings has been revised 9.1% downward over the last 60 days.
Equity Bancshares (EQBK - Free Report) is a bank holding company primarily in Kansas and Missouri that provides financial services primarily to businesses, business owners and individuals. The Zacks Consensus Estimate for its current year earnings has been revised 5.5% downward over the last 60 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Brainsway (BWAY - Free Report) is a commercial stage medical device company which is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. The Zacks Consensus Estimate for its current year earnings has been revised almost 10.81% downward over the last 60 days.
CareMax (CMAX - Free Report) is a technology-enabled care platform providing value-based care and chronic disease management to seniors. The Zacks Consensus Estimate for its current year earnings has been revised 9.1% downward over the last 60 days.
Equity Bancshares (EQBK - Free Report) is a bank holding company primarily in Kansas and Missouri that provides financial services primarily to businesses, business owners and individuals. The Zacks Consensus Estimate for its current year earnings has been revised 5.5% downward over the last 60 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on EQBK - FREE
Get the latest research report on BWAY - FREE
Get the latest research report on CMAX - FREE